Offering the ability to scale-up to various automated bioreactors with increased speed for T cell culture, PRIME-XV T Cell CDM is fully optimized for immune therapy and research. Chemically-defined and animal component-free, it delivers consistent growth while maintaining T cell functionality and potency in scalable therapy or research.</p>
PRIME-XV T Cell CDM is the first commercially available chemically-defined, animal component-free medium for the expansion and cultivation of human T cells. The performance and functionality of PRIME-XV T Cell CDM continues to set the standard as the application process becomes more dynamic and closed.
Provides optimal performance:
Supports vigorous T cell growth in static and dynamic automation systems while maintaining functionality
Provides lot-to-lot consistency for reliable formulation composition
Removes the effects of undefined components to minimize unwarranted T cell phenotypes
Supports polarization to targeted T cell types such as Th1 and T regulatory cells to further possible therapy applications
Manufactured to facilitate transfer from research to clinic:
Chemically-defined, animal component-free formula minimizes risks from adventitious agents
Manufactured in compliance with cGMP regulations
Traceability documentation provided including Certificates of Analysis, Certificates of Origin, and a Drug Master File (DMF) filed with the US FDA
Extensive QA testing including functionality, sterility, and endotoxin
Custom formulation, sizes and packaging available for all commercially available automation systems
PRIME-XV T Cell CDM supports viable T cell expansion across different culture vessels
Figure 1: (A) Fold expansion of CD3+ cells in PRIME-XV T Cell CDM is robust across the three documented culture systems, performing as well as or better than FBS-supplemented RPMI and commercially available XSF media. (B) Viability is maintained at or above 85% by the end of the culture period in all three cell culture systems. Though significant inter-donor variability is observed, these data are representative of three donors, analyzed on day 14 (plates, flasks and G-Rex) or day 9 (Quantum bioreactors).
Publication, presentation, and protocol available for download
Protocols support G-Rex and Quantum
Protocols for plates and flasks can be provided upon request
This product is shipped at 2-8°C with cold packs. Upon receipt, store immediately at 2-8°C and protect from light.
Handle using aseptic techniques to avoid contamination. Unopened liquid medium is stable for 24 months from date of manufacture, as indicated on the label.